GPI pulse™ - Global Pricing Innovations, International Reference Pricing - Pharma Data

GPI pulse™ is a dynamic value, price, and access analytics platform, utilising powerful algorithms to combine multiple data streams in a way that will give you unique insight into the full market access journey. This powerful platform is designed to be used as part of GPI’s comprehensive solution for pricing and market access strategy, but can also be leveraged to rapidly extract customised sets of analysis-ready data. To complement the price, reimbursement, and treatment cost data, GPI closely track policy events, regulatory and legislative updates, including international reference pricing changes, that could influence the price and reimbursement landscape. Each market has a set of formal and informal reference pricing rules which GPI collects from a range of public sources, primarily legislation. Use cases: - Clearly identify reference and reference countries for each market with our IRP matrix - Power your IRP simulations with up-to-date international reference pricing rules - Remove the burden of tracking IRP globally with timely updates - Understand formal and informal reference rules and the relationship between stakeholders and markets GPI continually invest in technology, taxonomy, and quality assurance, to ensure our data is the gold-standard in terms of accuracy, granularity, and timeliness. GPI pulse™ supports the full spectrum of biopharma clients, from top tier pharma to clinical stage biotech. The analytics tools within GPI pulse™ are built specifically with pricing, market access, and commercial strategy teams in mind. FREE DATA SAMPLES AVAILABLE: - Pricing - Cost of Treatment - Reimbursement and HTA

搜集汇总

背景与挑战

背景概述

GPI pulse™是一个动态的全球药品定价与市场准入分析平台，通过算法整合多源数据，提供对价格、报销、治疗成本及国际参考定价规则的深入洞察。该平台专为生物制药企业的定价和商业策略设计，支持从法规更新到模拟分析的全流程，并提供免费的定价与报销数据样本。